论文部分内容阅读
本文旨在研究急性心肌梗塞后,用常规利多卡因预防治疗时,利多卡因处置与病人年龄间的关系,并探讨体重和心衰在各种变化中的作用。方法:选35例因急性心肌梗塞接受预防性利多卡因治疗且无肝、肾功能衰竭的患者,所有病例均连续恒定滴注利多卡因至少18 h。药物的应用均按医嘱,于停止滴注后0、1、2、3、4、6、8、16和24 h 由输液对侧肢体抽取血标本,用反相HPLC 法测定利多卡因及其主
This article aims to investigate the relationship between lidocaine treatment and patient’s age in the prevention and treatment of conventional lidocaine after acute myocardial infarction and to explore the role of body weight and heart failure in various changes. Methods: A total of 35 patients with prophylactic lidocaine for acute myocardial infarction without liver and renal failure were enrolled in this study. Continuous infusion of lidocaine was continued for at least 18 h in all cases. Blood samples were drawn from contralateral limbs at 0, 1, 2, 3, 4, 6, 8, 16 and 24 h after stop infusion as determined by the physician and determined by reverse phase HPLC the Lord